Latest Asia Pacific News

GenusPlus has landed a $110 million turnkey contract to engineer, build, and commission the Koolunga Battery Energy Storage System in South Australia, marking a major milestone in its clean energy infrastructure push.

De.mem Limited has extended its growth streak with record quarterly cash receipts of approximately $10.4 million, a 31% increase year-on-year, alongside positive operating cash flow of $504,000 for the March 2026 quarter.

Ainsworth Game Technology’s FY25 results reveal a mixed bag: a 9% dip in underlying profit to $21.1 million, a hefty $43.1 million goodwill impairment tied to North America, and a strategic pivot with a new acting CEO. Strong Asia Pacific growth and new product launches contrast with margin pressures and a shrinking cash position.

Cycliq Group’s Q3 FY2026 customer receipts fell 23% year-on-year to $561k, though a late March UpRide Birthday campaign injected $256k in revenue. Operating cash outflows reflect prior quarter cost settlements, with hopes for cost normalisation and sales momentum in Q4.

Yancoal Australia posted a record 38.6 million tonnes of attributable saleable coal in 2025, up 5% on 2024, but net profit after tax plunged 64% to A$440 million amid softer coal prices. The miner maintained disciplined cost control and declared A$769 million in fully franked dividends.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.

Recce Pharmaceuticals has cleared a critical regulatory hurdle in Indonesia with a successful inspection of its Phase 3 clinical trial site for diabetic foot infections, paving the way for potential approval in 2026 amid a large and growing market.

AdAlta, Oribiotech, and Cell Therapies have inked a Memorandum of Understanding to deploy Oribiotech’s IRO automated cell therapy manufacturing platform in Australia and Asia Pacific, aiming to slash costs and boost production speed for CAR-T therapies.

DXN Limited has secured a A$5.3 million contract to deliver a modular Cable Landing Station in South America, marking its first foray into the Latin American market and reinforcing its role in hyperscale internet infrastructure.

Advanced Innergy Holdings has formalised its $0.40 per share offer to acquire Matrix Composites via a scheme of arrangement, aiming to expand its subsea manufacturing footprint across the Asia-Pacific region.

Henderson Far East Income Limited posted a robust 23.3% net asset value total return for the half-year ending February 2026, supported by strong Asian tech and financial sector gains. The trust declared a 6.25p interim dividend and raised £39.1 million through new share issuance, securing a spot in the FTSE 250.

ReNerve has moved its NervAlign Nerve Guide Matrix into stage 3 of commercial development, a key step toward FDA submission and eventual market entry. This progress supports the company’s ambition to provide surgeons with an alternative to donor nerves for repairing severe peripheral nerve injuries.